Literature DB >> 2340493

Cytogenetics of breast cancer.

D Geleick1, H Müller, A Matter, J Torhorst, U Regenass.   

Abstract

Chromosome counts were performed on 1,100 cells from 17 malignant breast carcinomas and on 168 cells of four normal tissue samples after amethopterin treatment and G-banding. Karyotypes were established from 216 cells of 11 tumor-derived cultures and from 47 cells of four nonmalignant tissue-derived cultures. Karyotypes of cells from nonmalignant samples showed a normal diploid chromosomal constitution with no consistent loss or gain of a specific chromosome. Structural chromosomal abnormalities were not observed. Tumor-derived cultures could be distinguished from normal cultures on the basis of a significantly increased incidence of numerical changes and structural chromosomal aberrations. In nine of 11 tumor-derived cultures, numerically normal cells were shown to be pseudodiploid, with frequencies ranging to 43% (mean, 13.2%) of the diploid cells. In agreement with previous reports, cytogenetic analyses showed predominantly diploid cells. Clonal numerical changes of chromosomes 17, 18, 20, and 21 could be detected in three tumor samples. Clonal structural abnormalities could be observed in two of 11 analyzed tumours. A t(6;12)(p21;p13) and an enlarged chromosome 7 (7q+) were found in a patient with invasive ductal carcinoma. An inversion of chromosome 7 [inv(7)(q11.2q32)] was observed in one case, also diagnosed as invasive ductal carcinoma. The significance of these findings in relation to clinical data is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340493     DOI: 10.1016/0165-4608(90)90107-l

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Cellular epigenetics: effects of passage history on competence of cells for "spontaneous" transformation.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

2.  Chromosomal instability in breast cancer patients.

Authors:  L Barrios; M R Caballín; R Miró; C Fuster; F Guedea; A Subias; J Egozcue
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

Review 3.  Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.

Authors:  Monica M Reinholz; Amy K Bruzek; Daniel W Visscher; Wilma L Lingle; Matthew J Schroeder; Edith A Perez; Robert B Jenkins
Journal:  Lancet Oncol       Date:  2009-03       Impact factor: 41.316

4.  Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.

Authors:  H X An; M W Beckmann; G Reifenberger; H G Bender; D Niederacher
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

5.  Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics.

Authors:  H Engel; C Kleespies; J Friedrich; M Breidenbach; A Kallenborn; T Schöndorf; H Kolhagen; P Mallmann
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

6.  Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci.

Authors:  M R Teixeira; N Pandis; G Bardi; J A Andersen; N Mandahl; F Mitelman; S Heim
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.